THE TREATMENT'S OUTCOMES OF THE SECONDARY ACUTE MYELOID LEUKEMIA-RETROSPECTIVE MULTICENTER PALG STUDY

被引：0
|
作者：
Grosicki, S. [1 ]
Bodzenta, E. [1 ]
Ilona, S. [1 ]
Wierzbowska, A. [2 ]
Kuydowicz, M. [2 ]
Joks, M. [3 ]
Czyz, A. [3 ]
Patkowska, E. [4 ]
Warzocha, K. [4 ]
Watek, M. [5 ]
Pasiarski, M. [5 ]
Piatkowska-Jakubas, B. [6 ]
机构：
[1] SPZOZ ZSM Chorzowie, Dept Hematol, Chorzow, Poland
[2] Med Univ Lodz, Dept Hematol, Lodz, Poland
[3] Med Univ, Dept Hematol, Poznan, Poland
[4] Inst Hematol & Transfusiol, Dept Hematol, Warsaw, Poland
[5] Swietokrzyskie Ctr Onkol, Dept Hematol, Kielce, Poland
[6] Jagiellonian Univ, Dept Hematol, Krakow, Poland
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P838
引用
收藏
页码：308 / 309
页数：2
相关论文
共 50 条
  • [41] Efficacy of azacitidine in acute myeloid leukemia: A retrospective study
    Gerber, B.
    Gemuenden, C.
    Goede, J. S.
    Senn, O.
    Benz, R.
    Manz, M. G.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
  • [42] Secondary acute myeloid leukemia occurring after successful treatment of acute promyelocytic leukemia
    Chen, Junfa
    Zheng, Zhiyin
    Shen, Jianping
    Peng, Leijun
    Zhuang, Haifeng
    Liu, Wenbin
    Zhou, Yuhong
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (03) : 327 - 328
  • [43] The clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study.
    Korkmaz, Serdal
    Dal, Mehmet Sinan
    Berber, Ilhami
    Sahin, Deniz Goren
    Dogu, Mehmet Hilmi
    Ayyildiz, Orhan
    Nizam, Ilknur
    Albayrak, Murat
    Esen, Ramazan
    Namdaroglu, Sinem
    Sencan, Mehmet
    Akay, Olga Meltem
    Hacioglu, Sibel Kabukcu
    Yildirim, Rahsan
    Eser, Ali
    Tombak, Anil
    Pala, Cigdem
    Ilhan, Osman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Treatment responses,outcomes,and prognostic factors associated with them in patients with secondary acute myeloid leukemia
    马玲
    [J]. China Medical Abstracts (Internal Medicine), 2023, 40 (02) : 120 - 121
  • [45] A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia
    Bazinet, Alexandre
    Darbaniyan, Faezeh
    Kadia, Tapan M.
    Venugopal, Sangeetha
    Kanagal-Shamanna, Rashmi
    DiNardo, Courtney D.
    Borthakur, Gautam
    Jabbour, Elias J.
    Daver, Naval G.
    Pemmaraju, Naveen
    Konopleva, Marina Y.
    Ravandi, Farhad
    Sasaki, Koji
    Chien, Kelly S.
    Hammond, Danielle
    Pierce, Sherry A.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    [J]. CANCER, 2023, 129 (04) : 560 - 568
  • [46] Daunorubicin, cytarabine and fludarabine (DAF) for the treatment of relapsed/refractory acute myeloid leukemia. Phase II study by the polish adult leukemia group (PALG)
    Holowiecki, J
    Grosicki, S
    Krzemien, S
    Skotnicki, A
    Warzecha, K
    Zdziarska, B
    Stella-Holowiecka, B
    Krawczyk-Kulis, M
    Kopera, M
    Wojciechowska, M
    [J]. BLOOD, 2004, 104 (11) : 210B - 210B
  • [47] The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study
    Wrzesien-Kus, A
    Robak, T
    Jamroziak, K
    Wierzbowska, A
    Dmoszynska, A
    Adamczyk-Cioch, M
    Kuliczkowski, K
    Mazur, G
    Holowiecki, J
    Konopka, L
    Maj, S
    Marianska, B
    Zawilska, K
    [J]. NEOPLASMA, 2002, 49 (06) : 405 - 411
  • [48] Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study
    Tachibana, Takayoshi
    Andou, Taiki
    Tanaka, Masatsugu
    Ito, Satomi
    Miyazaki, Takuya
    Ishii, Yoshimi
    Ogusa, Eriko
    Koharazawa, Hideyuki
    Takahashi, Hiroyuki
    Motohashi, Kenji
    Aoki, Jun
    Nakajima, Yuki
    Matsumoto, Kenji
    Hagihara, Maki
    Hashimoto, Chizuko
    Taguchi, Jun
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Fujisawa, Shin
    Kanamori, Heiwa
    Nakajima, Hideaki
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (06): : 415 - 421
  • [49] Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients; a retrospective, multicenter PALG study
    Grosicki, S.
    Holowiecki, J.
    Kuliczkowski, K.
    Skotnicki, A. B.
    Hellmann, A.
    Sulek, K.
    Dmoszynska, A.
    Kloczko, J.
    Jedrzejczak, W. W.
    Zdziarska, B.
    Warzocha, K.
    Wierzbowska, A.
    Komarnicki, M.
    Pluta, A.
    Giebel, S.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : 5611 - 5611
  • [50] Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study
    Takaoka, Kensuke
    Koya, Junji
    Yoshimi, Akihide
    Toya, Takashi
    Kobayashi, Takashi
    Nannya, Yasuhito
    Nakazaki, Kumi
    Arai, Shunya
    Ueno, Hironori
    Usuki, Kensuke
    Yamashita, Takeshi
    Imanishi, Daisuke
    Sato, Shinya
    Suzuki, Kenshi
    Harada, Hironori
    Manabe, Atsushi
    Hayashi, Yasuhide
    Miyazaki, Yasushi
    Kurokawa, Mineo
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1688 - 1694
12345